Immy

Bringing Diagnostics closer to the patient. IMMY is a global leader in fungal and infectious disease diagnostics. Headquartered in Norman, Oklahoma since 1979, we design, manufacture, and distribute affordable and reliable diagnostic tests that bring diagnostics closer to the patient and improve clinical outcomes around the world. IMMY is committed to addressing the global challenges of delayed, inaccurate, and inaccessible fungal diagnostics by delivering innovative, high-quality solutions that ensure the right information reaches the right people at the right time. We empower healthcare providers to make informed treatment decisions that improve outcomes for patients worldwide. Through this commitment, we reduce diagnostic gaps and enhance the speed and precision of fungal disease detection, keeping the patient at the center of everything we do. With a legacy rooted in mycology and a mission to save lives, IMMY’s rapid diagnostic tools, including our flagship CrAg® LFA, help detect life-threatening infections in immunocompromised patients and elevate the standard of care in over 100 countries. Our values, compassion, innovation, simplicity, integrity, customer focus, and teamwork, drive every decision we make. Recognized as a Top Workplace and Biotech Innovator of the Year, IMMY is also one of Oklahoma’s fastest-growing life science companies. Join us in shaping the future of global health.